Download
1 / 1
10 likes | 119 Vues
Explore the latest advancements in antibody engineering and its potential in developing effective therapies. Learn about protein sequences, structure, and design strategies.
E N D
VHCDR-1 CDR-2 1 E V Q L V E S G G G L V Q P G G S L R L S C A A S G F T F S S Y A* * * * M S W V R Q A P G K G L E W V S A I S G S G G S T * * *C1 1 E V Q L V E S G G G L V Q P G G S L R L S C A G S G F T F S S Y A * * * * M H W V R Q A P G K G L E W V S A I G T G G G T * * * * D11 1 E V Q L V E S G G G L V Q P G G S L R L S C A A G G F T F S S Y A * * * * M H W V R Q A P G K G L E W V S A I G T G G G T * * * * A 8 CDR-3 63 Y Y A D S V K G R F T I S R D N S K N T L Y L Q M N S L R A E D T A V Y Y C A R S D A A G N P S R * * *W G Q G T L V T VC1 62 Y Y A D S V K G R F T I S R D N A K N S L Y L Q M N S L R A E D T A V Y Y C A R NR G A P G I D K V T* W G Q G T L V T V D11 62 Y Y A D S V K G R F T I S R D N A K N S L Y L Q M N S L R A E D T A V Y Y C A RL W G R A S S T Q E P N W G Q G T L V T V A8 VL CDR-1 CDR-2 1 S S E L T Q D P A V S V A L G Q T V R I T C Q G D S L R S Y Y * * * * * * A S W Y Q Q K P G Q A P V L V I Y G K N N * * * * * * * C1 CDR-3 54 R P S G I P D R F S G S S S G N T A S L T I T G A Q A E D E A D Y Y C N S R D S S G N H A Y V F G G G T K L T V L G C1
